Search Results 491-500 of 18329 for prednisone

  1. Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Subjects who are currently using more than 5mg/day of prednisone (or an equivalent glucocorticoid exceeding physiologic replacement levels). Prior treatment ...

  2. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    ... prednisone 10 mg daily. Clinically-not controlled chronic or ongoing infectious disease requiring treatment at the time of first dose or within the 14 days ...

  3. Piroxicam (oral route) - Mayo Clinic

    Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and help relieve symptoms of arthritis (eg, osteoarthritis, rheumatoid arthritis), ...

  4. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

    Participation eligibility · Adrenal replacement (dose of ≤10 mg daily of prednisone or equivalent); · Topical, ocular, intra-articular, intranasal, or ...

  5. Vonoprazan, amoxicillin, and clarithromycin (oral route) - Side effects & dosage - Mayo Clinic

    Prednisone; Repaglinide; Rivaroxaban; Tipranavir. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating ...

  6. Blepharitis - Diagnosis & treatment - Mayo Clinic

    Examination of eyelashes under a microscope can show excess eyelash mites. Response to treatments generally confirm the diagnosis of blepharitis. If there is no ...

  7. A Study to Assess the Aria CV Pulmonary Hypertension System to Treat Pulmonary Arterial Hypertension - Mayo Clinic

    ... Prednisone at a dose \> 12 mg per day at time of enrollment; ii. Excluded if any immunosuppressant other than Mycophenolate mofetil, Rituximab or Prednisone ...

  8. Bone fractures and thinning bones, called osteoporosis. Fatigue, loss of appetite, nausea and muscle weakness. Thin skin, bruising and slower wound healing.

  9. Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Exception: Corticosteroid dose equivalent >10 mg/day prednisone is acceptable if physiological levels require, so long as the dose is stable for at least 7 days ...

  10. SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab - Mayo Clinic

    Subjects with a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications ...